Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
$182.50
$182.82
$99.91
$187.45
$40.34B1.253.31 million shs10 shs
Alteryx, Inc. stock logo
AYX
Alteryx
$48.26
$48.16
$27.92
$59.65
$3.49B0.492.14 million shs6.82 million shs
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
$464.86
+2.6%
$430.18
$279.86
$490.09
$5.86B0.9148,841 shs126,686 shs
Halliburton Company stock logo
HAL
Halliburton
$21.68
+2.2%
$20.77
$18.72
$37.08
$18.23B1.1311.35 million shs14.62 million shs
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
$91.27
+0.1%
$86.71
$61.01
$91.80
$165.65B0.939.53 million shs6.12 million shs
Sonos, Inc. stock logo
SONO
Sonos
$11.22
+0.9%
$10.10
$7.63
$15.89
$1.34B2.041.99 million shs1.68 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Alteryx, Inc. stock logo
AYX
Alteryx
0.00%0.00%0.00%0.00%0.00%
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
+3.35%+1.07%+6.40%+13.07%+52.07%
Halliburton Company stock logo
HAL
Halliburton
+3.93%+1.85%+8.01%-17.72%-36.67%
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
-0.09%+2.09%+3.20%+15.90%+24.19%
Sonos, Inc. stock logo
SONO
Sonos
+2.87%+7.54%+9.34%+3.25%-22.88%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Alteryx, Inc. stock logo
AYX
Alteryx
0.632 of 5 stars
0.00.00.03.00.62.50.6
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
3.1856 of 5 stars
1.31.01.71.22.02.52.5
Halliburton Company stock logo
HAL
Halliburton
4.9028 of 5 stars
4.33.02.50.93.31.72.5
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
4.6096 of 5 stars
2.33.02.51.83.52.52.5
Sonos, Inc. stock logo
SONO
Sonos
0.9286 of 5 stars
1.12.00.00.02.03.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
0.00
N/AN/AN/A
Alteryx, Inc. stock logo
AYX
Alteryx
0.00
N/AN/AN/A
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
2.63
Moderate Buy$473.001.75% Upside
Halliburton Company stock logo
HAL
Halliburton
2.67
Moderate Buy$33.5354.64% Upside
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
2.68
Moderate Buy$89.40-2.05% Downside
Sonos, Inc. stock logo
SONO
Sonos
2.25
Hold$12.259.18% Upside

Current Analyst Ratings Breakdown

Latest SONO, GPI, ALXN, HAL, SCHW, and AYX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2025
Halliburton Company stock logo
HAL
Halliburton
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$22.00 ➝ $21.00
6/24/2025
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Hold
6/16/2025
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$510.00 ➝ $565.00
6/16/2025
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$97.00 ➝ $100.00
6/9/2025
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$65.00 ➝ $82.00
6/5/2025
Halliburton Company stock logo
HAL
Halliburton
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$27.00 ➝ $28.00
5/20/2025
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/20/2025
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$95.00 ➝ $113.00
5/16/2025
Halliburton Company stock logo
HAL
Halliburton
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$34.00 ➝ $28.00
5/15/2025
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$84.00 ➝ $97.00
5/14/2025
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
$6.07B6.65$22.81 per share8.00$53.24 per share3.43
Alteryx, Inc. stock logo
AYX
Alteryx
$970M3.60N/AN/A$2.63 per share18.35
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
$19.93B0.30$49.88 per share9.32$223.32 per share2.08
Halliburton Company stock logo
HAL
Halliburton
$22.94B0.81$4.34 per share5.00$12.01 per share1.81
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
$19.61B8.46$4.88 per share18.71$22.02 per share4.14
Sonos, Inc. stock logo
SONO
Sonos
$1.52B0.89$0.12 per share95.14$3.52 per share3.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
$603.40M$11.6059.6413.150.9310.89%23.43%15.06%N/A
Alteryx, Inc. stock logo
AYX
Alteryx
-$179M-$2.60N/AN/AN/A-18.46%-118.87%-7.21%N/A
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
$498.10M$35.6213.0510.371.132.27%17.96%5.50%7/23/2025 (Estimated)
Halliburton Company stock logo
HAL
Halliburton
$2.50B$2.399.077.423.319.31%24.01%9.81%7/18/2025 (Estimated)
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
$5.94B$3.3027.6617.520.9731.71%18.31%1.50%7/15/2025 (Estimated)
Sonos, Inc. stock logo
SONO
Sonos
-$38.15M-$0.59N/AN/AN/A-4.74%-15.00%-7.20%8/6/2025 (Estimated)

Latest SONO, GPI, ALXN, HAL, SCHW, and AYX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2025Q2 2025
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
$10.02N/AN/AN/A$5.65 billionN/A
7/18/2025Q2 2025
Halliburton Company stock logo
HAL
Halliburton
$0.57N/AN/AN/A$5.43 billionN/A
7/15/2025Q2 2025
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
$1.06N/AN/AN/A$5.64 billionN/A
4/24/2025Q1 2025
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
$9.68$10.17+$0.49$9.67$5.37 billion$5.51 billion
4/22/2025Q1 2025
Halliburton Company stock logo
HAL
Halliburton
$0.60$0.60N/A$0.24$5.28 billion$5.42 billion
4/17/2025Q1 2025
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
$1.01$1.04+$0.03$0.99$5.46 billion$5.60 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
N/AN/AN/AN/AN/A
Alteryx, Inc. stock logo
AYX
Alteryx
N/AN/AN/AN/AN/A
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
$2.000.43%N/A5.61%2 Years
Halliburton Company stock logo
HAL
Halliburton
$0.683.14%N/A28.45%4 Years
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
$1.081.18%N/A32.73%1 Years
Sonos, Inc. stock logo
SONO
Sonos
N/AN/AN/AN/AN/A

Latest SONO, GPI, ALXN, HAL, SCHW, and AYX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2025
Halliburton Company stock logo
HAL
Halliburton
quarterly$0.173.41%6/4/20256/4/20256/25/2025
5/13/2025
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
quarterly$0.500.45%6/2/20256/2/20256/16/2025
4/24/2025
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
quarterly$0.271.36%5/9/20255/9/20255/23/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
0.19
4.52
3.96
Alteryx, Inc. stock logo
AYX
Alteryx
4.42
1.45
1.45
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
0.89
1.00
0.27
Halliburton Company stock logo
HAL
Halliburton
0.69
1.98
1.46
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
0.53
0.53
0.53
Sonos, Inc. stock logo
SONO
Sonos
N/A
1.56
1.09

Institutional Ownership

CompanyInstitutional Ownership
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
82.94%
Alteryx, Inc. stock logo
AYX
Alteryx
72.37%
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
99.92%
Halliburton Company stock logo
HAL
Halliburton
85.23%
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
84.38%
Sonos, Inc. stock logo
SONO
Sonos
85.82%

Insider Ownership

CompanyInsider Ownership
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
4.03%
Alteryx, Inc. stock logo
AYX
Alteryx
13.56%
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
2.10%
Halliburton Company stock logo
HAL
Halliburton
0.56%
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
6.30%
Sonos, Inc. stock logo
SONO
Sonos
1.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alexion Pharmaceuticals, Inc. stock logo
ALXN
Alexion Pharmaceuticals
3,837221.02 millionN/AOptionable
Alteryx, Inc. stock logo
AYX
Alteryx
2,30072.27 million62.47 millionOptionable
Group 1 Automotive, Inc. stock logo
GPI
Group 1 Automotive
20,41312.94 million12.66 millionOptionable
Halliburton Company stock logo
HAL
Halliburton
48,000859.72 million854.90 millionOptionable
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
32,1001.82 billion1.70 billionOptionable
Sonos, Inc. stock logo
SONO
Sonos
1,708120.09 million117.93 millionOptionable

Recent News About These Companies

Sonos is offering a refurbished Era 100 for just $119
Sonos Google Assistant - Setup and review
Sonos (NASDAQ:SONO) Shares Up 4.6% on Insider Buying Activity
Sonos Ray Review

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alexion Pharmaceuticals stock logo

Alexion Pharmaceuticals NASDAQ:ALXN

Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also provides Strensiq for patients with hypophosphatasia; Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency; and Andexxa, a reversal agent for patients treated with rivaroxaban or apixaban. In addition, the company is developing ALXN1210 (Intravenous) that is in Phase III clinical trials for the treatment of gMG, NMOSD, ALS, COVID-19, and HSCT-TMA; ALXN1210 (Subcutaneous), which is in Phase III clinical trials for PNH and aHUS; ALXN1820 that is in Phase I clinical trial, a therapeutic antagonist of properdin; and ALXN1720, which is in Phase I clinical trial for the treatment of disease states involving dysregulated terminal complement activity. Further, it is developing ALXN1840 that is in Phase III clinical trials for the treatment of Wilson disease; ALXN1830, which are in Phase I clinical trials for neonatal Fc receptor; ALXN2040 and ALXN2050 to treat diseases associated with dysregulation of the complement alternative pathway; ALXN1850, an enzyme replacement therapy; ALXN2060 for treating transthyretin amyloidosis; and ALXN2075 for treatment of relapsed/refractory chronic lymphocytic leukemia. The company serves distributors, pharmacies, hospital, hospital buying groups, and other healthcare providers in the United States and internationally. Alexion Pharmaceuticals, Inc. has collaboration and license agreement with Halozyme Therapeutics, Inc.; and agreements with Dicerna Pharmaceuticals, Inc., Zealand Pharma A/S, Caelum Biosciences, Inc., Stealth BioTherapeutics Corp., and Affibody AB. The company was founded in 1992 and is headquartered in Boston, Massachusetts.

Alteryx stock logo

Alteryx NYSE:AYX

Alteryx, Inc., together with its subsidiaries, operates in the analytics automation business in the United States and internationally. The company's analytics platform automates tasks for workers across the analytics value chain. Its analytics platform comprises Alteryx Designer, a data profiling, preparation, blending, and analytics product; Alteryx Server, a server-based product for scheduling, sharing, and running analytic processes and applications in a web-based environment; Alteryx Intelligence Suite, a solution that provides automated modeling, optical character recognition, and natural language processing; and Alteryx Connect, a collaborative data exploration platform. The company's platform also offers Alteryx Analytics Cloud products comprising Alteryx Designer Cloud, a cloud-native data profiling, preparation, and data pipelining product used to create visual workflows or analytic processes; Alteryx Machine Learning, an automated machine learning product to build, validate, iterate, and explore machine learning models; Alteryx Auto Insights, an analytics solution that automates insights for business users; and Alteryx Location Intelligence, a cloud-native product used to create geospatial-based insights. In addition, it offers technical support, instruction, and customer services. The company serves retail, food services, consumer products, telecom and cable, media and entertainment, professional services, financial services, energy and utilities, public sector, manufacturing, travel and hospitality, healthcare and insurance, and technology industries. Alteryx, Inc. was founded in 1997 and is headquartered in Irvine, California.

Group 1 Automotive stock logo

Group 1 Automotive NYSE:GPI

$464.86 +11.98 (+2.65%)
Closing price 03:59 PM Eastern
Extended Trading
$458.60 -6.26 (-1.35%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Group 1 Automotive, Inc., through its subsidiaries, operates in the automotive retail industry in the United States and the United Kingdom. The company sells new and used cars, light trucks, and vehicle parts, as well as service and insurance contracts; arranges related vehicle financing; and offers automotive maintenance and repair services. Group 1 Automotive, Inc. was incorporated in 1995 and is headquartered in Houston, Texas.

Halliburton stock logo

Halliburton NYSE:HAL

$21.68 +0.47 (+2.22%)
Closing price 03:59 PM Eastern
Extended Trading
$21.67 -0.01 (-0.05%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Halliburton Company provides products and services to the energy industry worldwide. It operates through two segments, Completion and Production, and Drilling and Evaluation. The Completion and Production segment offers production enhancement services that include stimulation and sand control services; cementing services, such as well bonding and casing, and casing equipment; and completion tools that offer downhole solutions and services, including well completion products and services, intelligent well completions, and service tools, as well as liner hanger, sand control, and multilateral systems. This segment also provides electrical submersible pumps, as well as artificial lift services; production solutions comprising coiled tubing, hydraulic workover units, downhole tools, and pumping and nitrogen services; pipeline and process services, such as pre-commissioning, commissioning, maintenance, and decommissioning; and specialty chemicals and services. The Drilling and Evaluation segment offers drilling fluid systems, performance additives, completion fluids, solids control, specialized testing equipment, and waste management services; drilling systems and services; wireline and perforating services consists of open-hole logging, and cased-hole and slickline; and drill bits and services comprising roller cone rock bits, fixed cutter bits, hole enlargement, and related downhole tools and services, as well as coring equipment and services. This segment also provides cloud based digital services and artificial intelligence solutions on an open architecture for subsurface insights, integrated well construction, and reservoir and production management; testing and subsea services, such as acquisition and analysis of reservoir information and optimization solutions; and project management and integrated asset management services. Halliburton Company was founded in 1919 and is based in Houston, Texas.

Charles Schwab stock logo

Charles Schwab NYSE:SCHW

$91.27 +0.10 (+0.11%)
Closing price 03:59 PM Eastern
Extended Trading
$91.57 +0.30 (+0.33%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Charles Schwab Corporation, together with its subsidiaries, operates as a savings and loan holding company that provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services in the United States and internationally. The company operates in two segments, Investor Services and Advisor Services. It offers brokerage accounts with equity and fixed income trading, margin lending, options trading, futures and forex trading, and cash management capabilities, including certificates of deposit; third-party mutual funds through the Mutual Fund Marketplace and Mutual Fund OneSource service, as well as mutual fund trading and clearing services to broker-dealers; exchange-traded funds; advisory solutions for managed portfolios, separately managed accounts, customized personal advice for tailored portfolios, specialized planning, and full-time portfolio management; banking products comprising checking and savings accounts, first lien residential real estate mortgage loans, home equity lines of credit, and pledged asset lines; and trust custody services, personal trust reporting services, and administrative trustee services. It also provides digital retirement calculators; integrated web-, mobile-, and software-based trading platforms, real-time market data, options trading, premium research, and multi-channel access; self-service education and support tools; online research and analysis tools; equity compensation plan sponsors full-service recordkeeping for stock plans, stock options, restricted stock, performance shares, and stock appreciation rights; retirement plan services; mutual fund clearing services; and advisor services, including interactive tools and educational content. The Company operates through branch offices. The Charles Schwab Corporation was incorporated in 1971 and is headquartered in Westlake, Texas.

Sonos stock logo

Sonos NASDAQ:SONO

$11.22 +0.10 (+0.90%)
Closing price 04:00 PM Eastern
Extended Trading
$11.11 -0.11 (-0.97%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sonos, Inc., together with its subsidiaries, designs, develops, manufactures, and sells audio products and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers wireless, portable, and home theater speakers; components; and accessories. The company offers its products through approximately 10,000 third-party retail stores, including custom installers of home audio systems; and e-commerce retailers, as well as through its website. The company was formerly known as Rincon Audio, Inc. and changed its name to Sonos, Inc. in May 2004. Sonos, Inc. was incorporated in 2002 and is headquartered in Santa Barbara, California.